Kapitalradar

Swiss capital increases, read from the official gazette and scored for financing rounds.

updated every weekdayrelease r10data as of 8 Oct 2026

↺ Try a rewind: Soverli AG on 24 Sep 2025, 83 days before the round was announced
Latest available record · 8 Oct 2026

Release evaluation · 7 Oct 2026 · does not rewind · rules + Claude: precision 2%–100% (n=17), recall 16/30 announced rounds · rules-only: precision 1%–99% (n=29), recall 18/30 announced rounds · Methodology

Published by 9 Aug 2026
Drag the red line through time · ← → a day · Shift+← → a week. Later days aren’t drawn: they haven’t been published yet.
1733not yet publishedAug 25Sep 25Oct 25Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26

Scope · likely financings by canton

37 likely financings · 11 Jul 2026 – 9 Aug 2026 · the feed below shows one weekClick a canton to filter the feedMap: Natural Earth

Likely financing
Looks like new money from outside investors: Claude, reading the entry and the rule signals, scores it 0.60 or higher.
Undecided
Some financing signals, not enough to call it: a score from 0.35 to below 0.60, or no usable score.
Capital increased
No sign of a financing round: the pre-filter found nothing to send to Claude, or Claude scored it below 0.35. Typical causes are converted loans, assets contributed in kind, reserves turned into capital or a conversion to an AG.
Confirmed round
A financing announcement on startupticker.ch names the company and matches this increase.

Published 3–9 Aug 2026

44 capital increases · 4 shown
Showing: likely financings and confirmed rounds ▾
Show
Capital increases published 3–9 Aug 2026
CompanyStatusNominal share capital (CHF)
before → after		New shares, % of
post-step shares		Announced roundnot disclosed in the SHABSHAB publishedSource
Kairos Medical AGSO · Entwicklung, Herstellung und Vertrieb von sowie Handel mit medizinaltechnischen Gütern aller Art. Kann …SHAB publication HR02-1006724586Likely financingscore 0.802’313’205 → 3’376’034New shares 31.5%31.5%—5 Aug 2026SHAB publication HR02-1006724586
Micreos Pharmaceuticals AGZG · Die Gesellschaft bezweckt die Erforschung, die Entwicklung, die Herstellung, die Verwertung, den Erwerb und …SHAB publication HR02-1006724432Likely financingscore 0.80475’045.68 → 518’497.64New shares 8.4%8.4%—5 Aug 2026SHAB publication HR02-1006724432
uniqFEED AGZH · Die Gesellschaft bezweckt die Entwicklung, Herstellung, Wartung sowie den Vertrieb und die Bewerbung von …SHAB publication HR02-1006724172Likely financingscore 0.74568’133 → 649’294New shares 12.5%12.5%—5 Aug 2026SHAB publication HR02-1006724172
FreezyBoy AGZG · Die Gesellschaft bezweckt die Entwicklung und Produktion, den Vertrieb von und Handel mit …SHAB publication HR02-1006723462Likely financingscore 0.75100’000 → 142’856New shares 30.0%30.0%—4 Aug 2026SHAB publication HR02-1006723462

40 other capital increases published this week ▸